CONFORM-OH

Control, Fludrocortisone or Midodrine for the treatment of Orthostatic Hypotension: A Randomised Controlled Trial

 

Welcome to the CONFORM-OH trial

Sponsor: Newcastle upon Tyne Hospitals NHS Foundation Trust (NuTH)

Funder: National Institute for Health Research (NIHR) Health Technology Assessment programme

Trial Management: Newcastle Clincial Trials Unit (NCTU) - a fully registered UKCRC Clinical Trials Unit

 

This study is funded by the National Institute of Health Research (NIHR) Health Technology Assessment (HTA) programme (NIHR127385). The views expressed are those of the authors and not necessarily those of the NIHR, the Department of Health and Social Care. 

 

The information on this website is for UK Healthcare Professionals only.

Remote working

As a result of the COVID-19 pandemic the NCTU team are working remotely. The Newcastle University is conducting as much of its business as possible remotely, and via email rather than face to face or by telephone.